Artal Group’s Lexeo Therapeutics LXEO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-603,435	Closed	-$9.68M	–	53
2024 Q2	$9.68M	Sell	603,435 -198,281	-25%	-$3.18M	0.25%	40
2024 Q1	$12.6M	Buy	801,716 +198,281	+33%	+$3.11M	0.32%	36
2023 Q4	$8.1M	Buy	+603,435	New	+$8.1M	0.27%	36